跳至主要内容
临床试验/NCT01814696
NCT01814696终止不适用

The Effect of the MedSentry System on Medication Adherence for Patients With Congestive Heart Failure: A Pilot Study

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2013年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
26
试验地点
2
主要终点
Medical Outcomes Study (MOS) "Adhere"

研究概览

简要总结

The goal of this pilot study to evaluate the effect of the MedSentry system, a multi-faceted medication adherence device and reminder system, on medication adherence and clinical outcomes in heart-failure (HF) patients. We will also evaluate the usability and satisfaction derived from using this system.

We hypothesize that:

  1. The use of the MedSentry system will improve medication adherence in patients with a discharge diagnosis of HF.
  2. The improvement in adherence correlates with fewer hospitalizations and emergency department (ED) visits.
  3. The improvement in adherence correlates with better health-related quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who have successfully completed the Partners Connected Cardiac Care Program (CCCP)
  • Take at least 3 and no more than 10 different daily medications (including both prescription and non-prescription/over the counter medications) to treat Heart Failure (HF) and other comorbid disorders.
  • Take medications no more than 4 specified times each day (i.e. morning, afternoon, early evening, bedtime).
  • The patient must be able to open a pill bottle independently.
  • The patient must be able to sort and manage their own medications.
  • Hospitalization within the last 24 months.
  • Have a telephone or cell phone.
  • Live in the greater Boston area.
  • The patients must speak, read and write English.
  • The patients must not be either vision or hearing impaired (i.e., unable to hear an alarm similar to a clock alarm or oven alarm).
  • Patient must have an Massachusetts General Hospital (MGH) affiliated care provider.

排除标准

  • Dementia or other conditions precluding the participant from providing informed consent or from learning to use the MedSentry pillbox.
  • Home environment unsuitable for the MedSentry pillbox and other installed equipment.
  • Awaiting revascularization, cardiac resynchronization or heart transplant.
  • Patients with a coexisting terminal illness like cancer or Chronic Renal Failure (CRF) requiring dialysis.

结局指标

主要结局

Medical Outcomes Study (MOS) "Adhere"

时间窗: 3 months

Subject reported medication adherence. The Medical Outcomes Study (MOS) "Adhere" medication adherence measure consists of a single question that asks participants "How often did you take your medications as prescribed during the past 4 weeks?" Responses are recoded into a dichotomous measure of nonadherent (none, a little, some of the time) and adherent (most, all of the time).

次要结局

  • Number of Hospitalization Visits.(3 months)
  • Hospitalization, Length of Stay (Days)(3 months)
  • Number of Participants With 1 or More Emergency Department (ED) Visits.(3 months)
  • Number of Emergency Department (ED) Visits.(3 months)
  • Number of Participants With 1 or More Hospitalizations.(3 months)
  • Minnesota Living With Heart Failure Questionnaire (MLHFQ) Total Summary Score(Baseline, end 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joseph C. Kvedar

Dermatologist

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验